Publications by authors named "M Emberton"
Introduction: RECONCILE (ClinicalTrials.gov:NCT04340245) will identify molecular and radiomic markers associated with clinical progression and radiological progression events in a cohort of localised, newly diagnosed Gleason 3 + 4 tumours. Molecular markers will be correlated against standard of care MRI-targeted histology and oncological outcomes.
View Article and Find Full Text PDFArticle Synopsis
- Globally, while people are living longer, many experience a decline in health due to age-related diseases, highlighting the need for better classification systems to address these issues.
- A consensus meeting with 150 experts established criteria for identifying ageing-related pathologies, requiring a 70% agreement for approval among participants.
- The agreed criteria focus on conditions that progress with age, contribute to functional decline, and are backed by human studies, setting a foundation for future classification and staging efforts.
Background And Objective: The PRECISION and PRECISE trials compared magnetic resonance imaging targeted biopsy (MRI ± TB) with the standard transrectal ultrasound (TRUS) guided biopsy for the detection of clinically significant prostate cancer (csPCa). PRECISION demonstrated superiority of MRI ± TB over TRUS guided biopsy, while PRECISE demonstrated noninferiority. The VISION study is a planned individual patient data meta-analysis (IPDMA) comparing MRI ± TB with TRUS guided biopsy for csPCa diagnosis.
View Article and Find Full Text PDFArticle Synopsis
- International guidelines suggest that surgical removal of suspected localized renal cell carcinoma (RCC) is common, but some benign cases are identified post-surgery, highlighting a need for better non-invasive diagnostic tests.
- A systematic review was conducted on imaging tests' accuracy for T1 renal tumors, analyzing 27 studies involving over 2000 tumors, which highlighted various imaging modalities like CT, MRI, and PET scans.
- While [Tc]Tc-sestamibi SPECT/CT showed promising sensitivity and specificity, the optimal imaging strategy remains uncertain, calling for further research and standardization of diagnostic criteria across different imaging techniques.
Multiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional images. Avenues for achieving consistent high-quality acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, and artificial intelligence systems. The impact of these interventions on the final images needs to be quantified.
View Article and Find Full Text PDF